PAVmed (PAVM) Cash & Current Investments (2015 - 2025)

PAVmed has reported Cash & Current Investments for 11 years, with the latest figure at $1.5 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Current Investments rose 1.08% year-over-year to $1.5 million; the trailing twelve-month figure through Dec 2025 stood at $1.5 million (up 1.08% YoY), and the FY2025 full-year result was $1.5 million, up 1.08% from the prior year.
• Cash & Current Investments for Q4 2025 stood at $1.5 million, down from $3.4 million in the prior quarter.
• The five-year high for Cash & Current Investments was $77.3 million in Q4 2021, with the low at $1.5 million in Q4 2024.
• Average Cash & Current Investments over 5 years is $32.3 million, with a median of $31.8 million recorded in 2023.
• Year-over-year, Cash & Current Investments surged 510.31% in 2021 and plunged 92.44% in 2024.
• Tracing PAVM's Cash & Current Investments over 5 years: stood at $77.3 million in 2021, then tumbled by 48.56% to $39.7 million in 2022, then slumped by 50.59% to $19.6 million in 2023, then sank by 92.44% to $1.5 million in 2024, then grew by 1.08% to $1.5 million in 2025.
• The last three Cash & Current Investments figures came in at $1.5 million (Q4 2025), $3.4 million (Q3 2025), and $4.3 million (Q2 2025), per Business Quant data.

Peer Comparison